SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc.（SLS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
sls · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$3.20
Consensus
$2.80
-64.9% upside
Low
$2.40
Median: $2.8 · Last Close: $7.98
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$2.80
-64.9% upside
High Target
$3.2
-59.9%
Low Target
$2.4
-69.9%
Current Price
$7.98
as of today
Based on analyst price targets, the SLS stock price prediction for the next 12 months ranges from $2.4 to $3.2. The consensus SLS price forecast of $2.80 implies -64.9% upside from the current price of $7.98.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $8.38 | ↑ 5.00% |
1-day model range: $8.25–$8.51. Peak: $8.51 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | +120.0% |
| 2028 | $29 | +265.2% |
| 2029 | $40 | +397.8% |
| 2030 | $48 | +497.1% |
| 2031 | — | +562.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SLS · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-12 | Maxim Group | Maintains | Buy→Buy |
| 2025-07-16 | Maxim Group | Maintains | Buy→Buy |
| 2023-11-22 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-09-07 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-11-15 | Alliance Global Partners | Maintains | Buy→Buy |
| 2022-06-28 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2021-07-21 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2019-11-18 | Alliance Global Partners | Maintains | Buy→Buy |
| 2019-11-18 | Maxim Group | Maintains | Buy→Buy |
| 2019-11-18 | Maxim Group | Upgrade ↑ | Hold→Buy |
Wall Street analysts have recently issued updated ratings on SELLAS Life Sciences Group, Inc. (SLS) stock. Of the recent 17 rating actions, 3 were upgrades and 0 were downgrades. 5 analysts currently cover SLS.
分析师推荐趋势
SLS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$36M
↓ 64.5% YoY
Revenue Next Year
$44M
↑ 22.4% YoY
EPS This Year
$-0.21
EPS Next Year
$-0.15
↓ 28.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast SLS EPS of $-0.21 for the current fiscal year, based on estimates from 1 analysts. The SLS revenue forecast is $36M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SLS 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SLS 的共识目标价为 $2.80（-64.9% 上行空间），分析师共识为 Buy。
SLS 的短期预测（明日）为 $8.38（+5.00%）。 SLS 对 2027 年的股价预测均值为 $18。 SLS 对 2030 年的预测区间为 $40–$56。
SELLAS Life Sciences Group, Inc. 在 NASDAQ 上市，代码 SLS。SLS 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
SLS 预测 · 8 个问题根据 5 位华尔街分析师，SLS 的 12 个月平均目标价为 $2.80，最高 $3.20、最低 $2.40。若有图表，中位目标价可在上方查看。相对当前价 $7.98，隐含约 -64.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.